ImageneBio (IMA) Payables (2020 - 2025)

ImageneBio has disclosed Payables across 6 years of filings, most recently posting $1.4 million for Q4 2025.

• Payables for Q4 2025 came in at $1.4 million, down 72.8% year-over-year; the trailing twelve-month figure through Dec 2025 was $1.4 million (down 72.8% YoY), and the FY2025 annual result was $1.4 million, down 72.8% from the prior year.
• Payables came in at $1.4 million for Q4 2025 at ImageneBio, down from $2.1 million in the prior quarter.
• In the past five years, Payables ranged from a high of $5.3 million in Q4 2024 to a low of $512000.0 in Q2 2025.
• The 5-year median for Payables is $2.1 million (2022), against an average of $2.3 million.
• Across the five-year window, Payables soared 156.05% in 2024 and plunged 72.8% in 2025, its largest moves.
• ImageneBio's Payables stood at $2.4 million in 2021, then declined by 12.21% to $2.1 million in 2022, then decreased by 1.29% to $2.1 million in 2023, then surged by 156.05% to $5.3 million in 2024, then slumped by 72.8% to $1.4 million in 2025.
• The last three Payables figures came in at $1.4 million (Q4 2025), $2.1 million (Q3 2025), and $512000.0 (Q2 2025), per Business Quant data.